Desenvolvimento de procedimentos eletroanalíticos para a determinação simultânea de analgésicos em formulações farmacêuticas e fluidos biológicos empregando o eletrodo de diamante dopado com boro

• Ano de defesa: 2015
• Autor(a) principal: Santos, Anderson Martin dos
• Orientador(a): Fatibello Filho, Orlando
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de São Carlos; Câmpus São Carlos
• Programa de Pós-Graduação: Programa de Pós-Graduação em Química - PPGQ
• Palavras-chave em Português: Química analítica; Analgésicos; Eletrodo de diamante dopado com boro (DDB); Determinação simultânea; Fluídos biológicos; Amperometria de múltiplos pulsos
• Área do conhecimento CNPq: CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA ANALITICA
• Link de acesso: https://repositorio.ufscar.br/handle/20.500.14289/7339

In this master dissertation, electroanalytical procedures for the simultaneous determination of analgesics paracetamol (PAR) and codeine (COD) and, PAR and tramadol (TRA) in pharmaceutical samples and biological fluids using a cathodically pretreated boron-doped diamond electrode (BDDE) were developed. In the first procedure, the square-wave voltammetry (SWV) was employed for the simultaneous determination of PAR and COD, using as supporting electrolyte 0.2 mol L−1 acetate buffer (pH 4.0), and the analytical curves were linear in the concentration range from 0.2 to 95.8 μmol L−1 for PAR and from 0.2 to 95.8 μmol L−1 for COD, with detection limits (LODs) of 0.018 μmol L−1 and 0.014 μmol L−1, respectively. The second procedure developed for the simultaneous determination of PAR and COD was based on a flow injection analysis with multiple pulses amperometric detection (FIA-MPA), using as transport solution a 0.05 mol L−1 H2SO4 solution. The potential pulse application sequence in function of time was 950 mV / 200 ms (potential where only the PAR oxidation occurs) and 1400 mV / 100 ms (potential where both analytes suffers oxidation (PAR and COD)). The obtained analytical curves show linearity from 0.08 to 100.0 μmol L−1 for PAR and 0.05 to 10.0 μmol L−1 for COD, with LODs of 0.030 e 0.035 μmol L−1 for PAR and COD, respectively. The analytical frequency was estimated as being 90 determinations h−1. After, an electroanalytical procedure using FIA–MPA it was developed a simultaneous determination of PAR and TRA. The potential pulse application sequence in function of time was 850 mV / 200 ms (potential where only occurs the PAR oxidation) and 1600 mV / 100 ms (potential where both analytes suffers oxidation). The obtained analytical curves show linearities between 1.0 to 100.0 μmol L−1 and 0.08 to 10.0 μmol L−1 for PAR and TRA, respectively, and the LOD was 0.030 μmol L−1 for PAR and 0.040 μmol L−1 for TRA. Finally, all developed procedures were employed for the simultaneous determination of these compounds (PAR + COD e PAR + TRA) in pharmaceutical samples, where the obtained results agree with those results obtained using a comparative method (HPLC – High-performance liquid chromatography). These compounds were simultaneously analyzed in synthetic biological fluids (urine and human serum) by addiction and recuperation method, where the recuperations obtained ranged from 90.8 to 108%.